{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:33:28Z","timestamp":1780554808813,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,28]],"date-time":"2013-05-28T00:00:00Z","timestamp":1369699200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-244x-13-152","type":"journal-article","created":{"date-parts":[[2013,5,29]],"date-time":"2013-05-29T02:45:26Z","timestamp":1369795526000},"source":"Crossref","is-referenced-by-count":34,"title":["Tardive and spontaneous dyskinesia incidence in the general population"],"prefix":"10.1186","volume":"13","author":[{"given":"Ray M","family":"Merrill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L","family":"Lyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M","family":"Matiaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,28]]},"reference":[{"key":"1343_CR1","volume-title":"Stedman\u2019s medical dictionary for the health professions and nursing","author":"JK Stedman","year":"2005","unstructured":"Stedman JK: Stedman\u2019s medical dictionary for the health professions and nursing. 2005, Baltimore, MD: Lippincott Williams & Wilkins"},{"issue":"1","key":"1343_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1017\/S1092852912000752","volume":"18","author":"AJ Loonen","year":"2013","unstructured":"Loonen AJ, Ivanova SA: New insights into the mechanism of drug-induced dyskinesia. CNS Spectr. 2013, 18 (1): 15-20. 10.1017\/S1092852912000752.","journal-title":"CNS Spectr"},{"issue":"4","key":"1343_CR3","first-page":"15","volume":"61","author":"GM Glazer","year":"2000","unstructured":"Glazer GM: Review of incidence studies of tardive dyskinesia associated with typical antipsychotics. J Clin Psychiatry. 2000, 61 (4): 15-20.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"1343_CR4","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2105\/AJPH.77.6.717","volume":"77","author":"M Morganstern","year":"1987","unstructured":"Morganstern M, Glazer WM, Niedzwiecki D, Nouriah P: The impact of neuroleptic medication on tardive dyskinesia: a meta-analysis of published studies. AJPH. 1987, 77 (6): 717-724. 10.2105\/AJPH.77.6.717.","journal-title":"AJPH"},{"issue":"9","key":"1343_CR5","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.4088\/JCP.v66n0907","volume":"66","author":"DE Tenback","year":"2005","unstructured":"Tenback DE, van Harten PN, Slooff CJ, Belger MA, van Os J, SOHO Study Group: Effects of antipsychotic treatment on tardive dyskinesia: a 6-month evaluation of patients from the European Schizophrenia Outpatient Health Outcomes (SOHO) Study. J Clin Psychiatry. 2005, 66 (9): 1130-1133. 10.4088\/JCP.v66n0907.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"1343_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/YCO.0b013e3282f53132","volume":"21","author":"CU Correll","year":"2008","unstructured":"Correll CU, Schenk EM: Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatry. 2008, 21 (2): 151-156. 10.1097\/YCO.0b013e3282f53132.","journal-title":"Curr Opin Psychiatry"},{"key":"1343_CR7","volume-title":"Psychotropic Drugs","author":"NL Keltner","year":"2005","unstructured":"Keltner NL, Folks DG: Psychotropic Drugs. 2005, Maryland Heights, MO: Elsevier Mosby, 4","edition":"4"},{"issue":"9","key":"1343_CR8","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1176\/ajp.155.9.1202","volume":"155","author":"M Gervin","year":"1998","unstructured":"Gervin M, Browne S, Lane A, Clarke M, Waddington JL, Larkin C, O\u2019Callaghan E: Spontaneous abnormal involuntary movements in first-episode schizophrenia and schizophreniform disorder: baseline rate in a group of patients from an Irish catchment area. Am J Psychiatry. 1998, 155 (9): 1202-1206.","journal-title":"Am J Psychiatry"},{"key":"1343_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1192\/bjp.181.4.321","volume":"181","author":"RG McCreadie","year":"2002","unstructured":"McCreadie RG, Padmavati R, Thara R, Srinivasan TN: Spontaneous dyskinesia and parkinsonism in never-medicated, chronically ill patients with schizophrenia: 18-month follow-up. Br J Psychiatry. 2002, 181: 135-137.","journal-title":"Br J Psychiatry"},{"issue":"8","key":"1343_CR10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1001\/archpsyc.1994.03950080055008","volume":"51","author":"WS Fenton","year":"1994","unstructured":"Fenton WS, Wyatt RJ, McGlashan TH: Risk factors for spontaneous dyskinesia in schizophrenia. Arch Gen Psychiatry. 1994, 51 (8): 643-650. 10.1001\/archpsyc.1994.03950080055008.","journal-title":"Arch Gen Psychiatry"},{"issue":"6416","key":"1343_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1136\/bmj.288.6416.545","volume":"288","author":"BE Wiholm","year":"1984","unstructured":"Wiholm BE, Mortimer \u00d6, Boethius G, H\u00e4ggstr\u00f6m JE: Tardive dyskinesia associated with Metoclopramide. BMJ. 1984, 288 (6416): 545-547. 10.1136\/bmj.288.6416.545.","journal-title":"BMJ"},{"key":"1343_CR12","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/archinte.1993.00410120051007","volume":"153","author":"L Ganzini","year":"1993","unstructured":"Ganzini L, Casey DE, Hoffman WF, McCall AL: The prevalence of metoclopramide-induced Tardive Dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med. 1993, 153: 1469-1475. 10.1001\/archinte.1993.00410120051007.","journal-title":"Arch Intern Med"},{"key":"1343_CR13","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1001\/archpsyc.1980.01780250054006","volume":"37","author":"JM Smith","year":"1980","unstructured":"Smith JM, Baldessarini RJ: Changes in prevalence, severity and recovery in tardive diskinesia with age. Arch Gen Psychiatry. 1980, 37: 1368-1373. 10.1001\/archpsyc.1980.01780250054006.","journal-title":"Arch Gen Psychiatry"},{"issue":"4\u20135","key":"1343_CR14","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/BF02189535","volume":"240","author":"T Inada","year":"1991","unstructured":"Inada T, Ohnishi K, Kamisada M, Matsuga G, Tajima O, Hashiguchi K, Shima S, Oh-e Y, Masuda Y: A prospective study of tardive diskinesia in Japan. Eur Arch Psychiatry Clin Neurosci. 1991, 240 (4\u20135): 250-254.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1343_CR15","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1176\/ajp.150.6.966","volume":"150","author":"MG Woerner","year":"1993","unstructured":"Woerner MG, Saltz BL, Kane JM, Lieberman JA, Alvir JMJ: Diabetes and development of tardive diskinesia. Am J Psychiatry. 1993, 150: 966-968.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"1343_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/archpsyc.1991.01810270071010","volume":"48","author":"L Ganzini","year":"1991","unstructured":"Ganzini L, Heintz RT, Hoffman WF, Casey DE: The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study. Arch Gen Psychiatry. 1991, 48 (3): 259-263. 10.1001\/archpsyc.1991.01810270071010.","journal-title":"Arch Gen Psychiatry"},{"key":"1343_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/hup.354","volume":"17","author":"M Raja","year":"2001","unstructured":"Raja M, Azzoni A: Diabetes is not a risk factor for tardive dyskinesia. A retrospective observational study. Hum Psychopharmacol Clin Exp. 2001, 17: 61-63.","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"3","key":"1343_CR18","first-page":"138","volume":"3","author":"JP Pasricha","year":"2006","unstructured":"Pasricha JP, Pelivanov N, Sugumar A, Jankovic J: Drug insight: from disturbed motility to disordered movement- a review of the clinical benefits and medicological risks of metoclopramide. Nature. 2006, 3 (3): 138-148.","journal-title":"Nature"},{"issue":"2","key":"1343_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.disamonth.2010.12.007","volume":"57","author":"DM Tang","year":"2011","unstructured":"Tang DM, Friedenberg FK: Gastroparesis: approach, diagnostic evaluation, and management. Dis Mon. 2011, 57 (2): 74-101. 10.1016\/j.disamonth.2010.12.007.","journal-title":"Dis Mon"},{"issue":"5","key":"1343_CR20","first-page":"617","volume":"81","author":"J Muench","year":"2010","unstructured":"Muench J, Hamer AM: Adverse effects of antipsychotic medications. Am Fam Physician. 2010, 81 (5): 617-622.","journal-title":"Am Fam Physician"},{"issue":"3","key":"1343_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1177\/002383099200500305","volume":"5","author":"RA Sweet","year":"1992","unstructured":"Sweet RA, Mulsant BH, Rifai AH, Zubenko GS: Dyskinesia and neuroleptic exposure in elderly psychiatric inpatients. J Geriatr Psychiatry Neurol. 1992, 5 (3): 156-161.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"9","key":"1343_CR22","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1176\/ajp.149.9.1206","volume":"149","author":"R Yassa","year":"1992","unstructured":"Yassa R, Nastase C, Dupont D, Thibeau M: Tardive dyskinesia in elderly psychiatric patients: a 5-year study. Am J Psychiatry. 1992, 149 (9): 1206-1211.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"1343_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2478\/v10039-009-0022-7","volume":"54","author":"RM Merrill","year":"2009","unstructured":"Merrill RM, Lyon JL, Baker RK, Gren LH: Attention deficit hyperactivity disorder and increased risk of injury. Adv Med Sci. 2009, 54 (1): 20-26.","journal-title":"Adv Med Sci"},{"issue":"4","key":"1343_CR24","first-page":"91","volume":"38","author":"RM Merrill","year":"1999","unstructured":"Merrill RM, Lindsay GB, Lyon JL: Tobacco-related cancers in the Utah compared to the United States: Quantifying the benefits of the Word of Wisdom. BYU Studies. 1999, 38 (4): 91-105.","journal-title":"BYU Studies"},{"key":"1343_CR25","volume-title":"International Classification of Diseases, 9th Revision; Clinical Modification","author":"ICD-9-CM","year":"2006","unstructured":"ICD-9-CM: International Classification of Diseases, 9th Revision; Clinical Modification. 2006, Los Angeles, CA: PMIC, 7","edition":"7"},{"key":"1343_CR26","first-page":"486","volume":"39","author":"NR Schooler","year":"1982","unstructured":"Schooler NR, Kane JM: Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry. 1982, 39: 486-","journal-title":"Arch Gen Psychiatry"},{"key":"1343_CR27","volume-title":"Basic Concepts in Pharmacology: What You Need to Know for Each Drug Class","author":"J Stringer","year":"2011","unstructured":"Stringer J: Basic Concepts in Pharmacology: What You Need to Know for Each Drug Class. 2011, New York, NY: McGraw-Hill Companies Inc., 4","edition":"4"},{"key":"1343_CR28","volume-title":"The American Psychiatric Publishing Textbook of Psychopharmacology","author":"FS Alan","year":"2009","unstructured":"Alan FS, Nemeroff CB: The American Psychiatric Publishing Textbook of Psychopharmacology. 2009, Arlington, VA: American Psychiatric Publishing, 4","edition":"4"},{"issue":"2","key":"1343_CR29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1176\/ajp.156.2.309","volume":"156","author":"DV Jeste","year":"1999","unstructured":"Jeste DV, Lacro JP, Palmer B, Rockwell E, Harris MJ, Caligiuri MP: Incidence of tardive dyskinesia in early stages of low-dose treatment with typical neuroleptics in older patients. Am J Psychiatry. 1999, 156 (2): 309-311.","journal-title":"Am J Psychiatry"},{"key":"1343_CR30","volume-title":"FDA requires boxed warning and risk mitigation strategy for Metoclopramide containing drugs: Agency warns against chronic use of these products to treat gastrointestinal disorders","author":"FDA News Release","year":"2009","unstructured":"FDA News Release: FDA requires boxed warning and risk mitigation strategy for Metoclopramide containing drugs: Agency warns against chronic use of these products to treat gastrointestinal disorders. 2009, http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm149533.htm ,"},{"key":"1343_CR31","first-page":"410","volume":"3","author":"C Blanes","year":"1991","unstructured":"Blanes C, Colom H, Moreno J, Obach R, Peraire C, Domenech J: Comparative study \u201cin vitro\u201d of transdermal absorption of a series of antiemetic drugs. Eur J Drug Metab Pharmacokinet. 1991, 3: 410-414.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"1","key":"1343_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jps.2600830108","volume":"83","author":"AC Calpena","year":"1994","unstructured":"Calpena AC, Blanes C, Moreno J, Obach R, Domenech J: A comparative in vitro study of transdermal absorption of antiemetics. J Pharm Sci. 1994, 83 (1): 29-33. 10.1002\/jps.2600830108.","journal-title":"J Pharm Sci"},{"key":"1343_CR33","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1017\/S0033291708004716","volume":"39","author":"S Pappa","year":"2009","unstructured":"Pappa S, Dazzan P: Spontaneous movement disorders in antipsychotic-naive patients with first-episode psychoses: a systematic review. Psychol Med. 2009, 39: 1065-1076. 10.1017\/S0033291708004716.","journal-title":"Psychol Med"},{"key":"1343_CR34","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/JCP.0b013e3181845f59","volume":"28","author":"J Lee","year":"2008","unstructured":"Lee J, Poon L, Chong S: Spontaneous dyskinesia in first-episode psychosis in a Southeast Asian population. J Clin Psychopharmacol. 2008, 28: 536-539. 10.1097\/JCP.0b013e3181845f59.","journal-title":"J Clin Psychopharmacol"},{"key":"1343_CR35","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/bmj.291.6500.930","volume":"291","author":"DN Bateman","year":"1985","unstructured":"Bateman DN, Rawlins MD, Simpson JN: Extrapyramidal reactions with metoclopramide. Brit Med J. 1985, 291: 930-932. 10.1136\/bmj.291.6500.930.","journal-title":"Brit Med J"},{"key":"1343_CR36","first-page":"133","volume":"54","author":"WM Glazer","year":"1993","unstructured":"Glazer WM, Morgenstern H, Doucette JT: Predicting long term risk of tardive dyskinesia in outpatients maintained on neuroleptic medication. J Clin Psychiatry. 1993, 54: 133-139.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"1343_CR37","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0006-3223(96)00289-2","volume":"41","author":"A Nilsson","year":"1997","unstructured":"Nilsson A, Waller L, Rosengren A, Adlerberth A, Wilhelmsen L: Cigarette smoking is associated with abnormal involuntary movements in the general male population\u2013a study of men born in 1933. Biol Psychiatry. 1997, 41 (6): 717-723. 10.1016\/S0006-3223(96)00289-2.","journal-title":"Biol Psychiatry"},{"issue":"3","key":"1343_CR38","first-page":"185","volume":"28","author":"SA Chong","year":"2003","unstructured":"Chong SA, Tan EC, Tan CH: Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene. J Psychiatry Neurosci. 2003, 28 (3): 185-189.","journal-title":"J Psychiatry Neurosci"},{"key":"1343_CR39","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/0006-3223(94)90077-9","volume":"36","author":"DD Sewell","year":"1994","unstructured":"Sewell DD, Kodsi AB, Caligiuri MP, Jeste DV: Metoclopramide and tardive dyskinesia. Biol Psychiatry. 1994, 36: 630-632. 10.1016\/0006-3223(94)90077-9.","journal-title":"Biol Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-13-152\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T23:51:08Z","timestamp":1688255468000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-13-152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,28]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1343"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-13-152","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,28]]},"article-number":"152"}}